Nasdaq Stockholm AB: ISR Immune System Regulation Holding AB (publ) receives observation status (432/22)

On August 31, 2022, ISR Immune System Regulation Holding AB (publ) published
its interim report for the second quarter of 2022 with information on the
company's financial situation. The rules of Nasdaq

Related Keywords

Stockholm ,Sweden , ,System Regulation Holding ,Nasdaq First North Growth Market ,Nasdaq Stockholm ,Nasdaq ,Immune ,System ,Regulation ,Molding ,Publ ,Eceives ,Observation ,Status ,